Mario Montanino Oliva
Overview
Explore the profile of Mario Montanino Oliva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Facchinetti F, Gambineri A, Aimaretti G, Ferlin A, Lagana A, Moghetti P, et al.
J Endocrinol Invest
. 2025 Jan;
PMID: 39831926
Purpose: To gather the current opinion among Italian gynecologists and endocrinologists regarding the definition, diagnosis, and treatment of polycystic ovary syndrome (PCOS). Method: A Delphi survey consisting of 26 statements...
2.
Fabiani M, Margiotti K, Libotte F, Ali C, Zangheri C, Barone M, et al.
J Assist Reprod Genet
. 2025 Jan;
42(2):693.
PMID: 39826058
No abstract available.
3.
Fabiani M, Margiotti K, Libotte F, Ali C, Zangheri C, Barone M, et al.
J Assist Reprod Genet
. 2024 Dec;
42(1):265-273.
PMID: 39693035
Purpose: Uniparental disomy (UPD) is a genetic condition which both copies of a chromosome are inherited from a single parent, potentially leading to imprinting disorders. This study aimed to assess...
4.
Myers S, Oliva M, Nordio M, Unfer V
Arch Gynecol Obstet
. 2024 Mar;
309(6):2307-2313.
PMID: 38502188
Polycystic ovary syndrome (PCOS) is defined as the combination of polycystic morphology, hyperandrogenism, and ovulatory disruption; this heterogeneity presents a conundrum for the medical community. The Rotterdam criteria have governed...
5.
Dinicola S, Unfer V, Soulage C, Yap-Garcia M, Bevilacqua A, Benvenga S, et al.
Gynecol Obstet Invest
. 2024 Feb;
89(4):284-294.
PMID: 38373412
Background: <sc>d</sc>-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. Objectives: This perspective seeks to...
6.
Beresniak A, Russo M, Forte G, Lagana A, Oliva M, Aragona C, et al.
Sci Rep
. 2023 Oct;
13(1):17789.
PMID: 37853019
Accumulating evidence suggests that oral supplementation with myo-Inositol (myo-Ins) is able to reduce the amount of gonadotropins and days of controlled ovarian hyperstimulation (COS) necessary to achieve adequate oocyte maturation...
7.
Parente E, Colannino G, Bilotta G, Espinola M, Proietti S, Oliva M, et al.
Clin Pract
. 2023 Sep;
13(5):1123-1129.
PMID: 37736936
Background-Pregnancy represents a nutritional challenge, since macro- and micronutrients intake can affect mother' health and influence negative outcomes. The aim of this retrospective pilot study is to evidence whether the...
8.
Palomba S, Carone D, Vitagliano A, Costanzi F, Fracassi A, Russo T, et al.
BMC Womens Health
. 2023 Jul;
23(1):397.
PMID: 37516869
Background: Endometrial scratching (ES) or injury is intentional damage to the endometrium performed to improve reproductive outcomes for infertile women desiring pregnancy. Moreover, recent systematic reviews with meta-analyses and randomized...
9.
Unfer V, Russo M, Aragona C, Bilotta G, Oliva M, Bizzarri M
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371854
Background: The aim of the present study is to investigate the effects produced by a treatment with myo-Inositol (myo-Ins) in women presenting polycystic ovary syndrome (PCOS) of different phenotypes. Methods:...
10.
Nordio M, Espinola M, Bilotta G, Capoccia E, Oliva M
J Clin Med
. 2023 Jan;
12(1).
PMID: 36615188
Background: Recent studies reported possible concerns following long-lasting treatments with high doses of D-chiro-inositol in women. However, to date, no clinical trial has investigated or validated these concerns. We addressed...